Retrospective study of the combination of TP and PF regimens with or without immune checkpoint inhibitors for the first-line treatment of locally advanced or advanced esophageal squamous cell carcinoma

OBJECTIVE: To investigate the efficacy and safety differences between the cisplatin + paclitaxel (TP) and cisplatin + fluorouracil (PF) regimens in combination with or without immune checkpoint inhibitors (ICIs) in advanced esophageal squamous cell carcinoma (ESCC) first-line treatment and prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhengfeng, Yang, Lei, Wang, Dazhen, Ruan, Yuli, Zhang, Jianji, Zhao, Lu, Yang, Liu, Lou, Changjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176547/
https://www.ncbi.nlm.nih.gov/pubmed/37188111
http://dx.doi.org/10.1177/17588359231169981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176547/
https://www.ncbi.nlm.nih.gov/pubmed/37188111
http://dx.doi.org/10.1177/17588359231169981

Ejemplares similares